Novartis Investigative Site

Piešťany, Slovak Republic 921 12

0 studies enrolling now · 2 studies all time

What they study most

Psoriatic Arthritis, Rheumatoid Arthritis

Studies at this site

• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) — Completed
• Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) — Completed